MiMedx Group Inc MDXG

US Biotechnology

$4.13 ▼ -3.28% ($-0.14)

Open $4.17

Prev Close $4.27

Day Range $3.97 – $4.21

52W Range $3.03 – $7.99

Market Cap $601.99M

P/E (TTM) 19.61

Beta 1.47

EPS (TTM) $0.20

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2007-08-20
Shares Out.	145,760,000
Website	mimedx.com/ ↗
Phone	17706519100
Employees	808
Revenue	$64.4M
Gross Profit	$44.4M
Net Income	-$14.8M
Free Cash Flow	$44.5M
Total Assets	$281.0M
Total Liabilities	$65.0M
Equity	$216.0M

About MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

MiMedx Group Inc is a publicly traded company under the ticker symbol MDXG on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.